amyloid plaque

Lilly

Pharma

Lilly's adjusted Kisunla regimen reduces brain swelling in trial

Eli Lilly looks to tweak the dosing regimen of its Alzheimer’s disease drug Kisunla after showing reduced side effect of brain swelling in a trial.

Kevin Dunleavy Oct 29, 2024 3:38pm

brain blood brain barrier mind head

Biogen's Aduhelm can't catch a break even in Alzheimer's trials

May 16, 2022 8:23am